Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01791296 · ClinicalTrials.gov registry record · Phase 4
Does Nightly Dexmedetomidine Improve Sleep and Reduce Delirium in ICU Patients?
A Phase 4 study of Delirium and Sleep Deprivation, sponsored by Maisonneuve-Rosemont Hospital.
- Completed
- Registry status
- Phase 4
- Development phase
- 100
- Enrollment target
- 2
- Study locations
NCT01791296 is a Phase 4 study of Delirium and Sleep Deprivation that has completed, run by Maisonneuve-Rosemont Hospital. The registered enrollment target is 100 participants, below the 886-participant average among 62 other Delirium trials with a reported enrollment target (89% lower). The trial reports 2 study locations across 2 states.
The verdict
NCT01791296, a Phase 4 study of Delirium and Sleep Deprivation, has completed, sponsored by Maisonneuve-Rosemont Hospital.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 100 participants
- Enrollment target
- 2
- Study locations
Study Summary
Specific Aims 1. Establish the feasibility of larger trial by implementing a sleep protocol in the ICU at 2 different sites. Specifically will be estimating the recruitment rates of patients and the compliance with both interventions. 2. Measure the safety and tolerance of adding night-time sedation with dexmedetomidine using adverse effects and withdrawal rates as indicators. 3. Measure the effect of nocturnal dexmedetomidine on pertinent clinical outcomes and use this outcome data to plan a larger, multicenter trial in this area. The goal of this study is to determine whether a night-time protocol that incorporates a pharmacologic intervention associated with improved sleep (i.e. dexmedetomidine) will improve sleep quality and reduce the incidence of delirium and sub-syndromal delirium in critically ill patients.
Conditions Studied
Interventions
- OTHER Placebo
- DRUG Dexmedetomidine
Study Locations (2)
Massachusetts
- Tufts Medical Center - Boston
Quebec
- Maisonneuve Rosemont Hospital - Montreal
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 100 participants |
| Start Date | 2011-01 |
| Est. Completion | 2016-12 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01791296
The ClinicalTrials.gov registry entry for NCT01791296 describes a study currently listed as completed, categorized as Phase 4. The registered enrollment target is 100 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 886-participant average among 62 other Delirium trials with a reported enrollment target (89% lower). The listed sponsor is Maisonneuve-Rosemont Hospital, which has 1 total studies on file at ClinicalTrials.gov.
The record links to 2 conditions, with Delirium appearing as the primary indexed condition, and to 2 interventions - of which Placebo is the first listed.
NCT01791296 reports 2 study locations spanning 2 distinct geographic areas - top geographies include Massachusetts, Quebec.
Frequently Asked Questions
What is clinical trial NCT01791296 about?
NCT01791296 is a clinical study titled "Does Nightly Dexmedetomidine Improve Sleep and Reduce Delirium in ICU Patients?". Specific Aims 1. Establish the feasibility of larger trial by implementing a sleep protocol in the ICU at 2 different sites. Specifically will be estimating the recruitment rates of patients and the compliance with both interventions. 2. Measure the safety and tolerance of adding night-time sedatio...
What is the current status of trial NCT01791296?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 100 participants. The study started on 2011-01. Estimated completion is 2016-12.
What conditions does trial NCT01791296 study?
This clinical trial studies the following conditions: Delirium, Sleep Deprivation.
What interventions are being tested in trial NCT01791296?
The interventions under investigation include: Placebo (OTHER), Dexmedetomidine (DRUG).
Who is sponsoring clinical trial NCT01791296?
This trial is sponsored by Maisonneuve-Rosemont Hospital, which has 1 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT01791296 being conducted?
This trial has 2 study locations across Massachusetts, Quebec. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Delirium
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Delirium Reduction With Ramelteon
RECRUITING · Phase 4
-
Preventing Post-Operative Delirium in Patients Undergoing a Pneumonectomy, Esophagectomy or Thoracotomy
COMPLETED · Phase 4
-
Researching Efficient Approaches to Delirium Identification-Sustaining Effective Translation
RECRUITING · NA
-
VoiceLove Digital Therapy for Delirium in the ICU
RECRUITING · NA
-
Delirium and Neuropsychological Recovery Among Emergency General Surgery Survivors
RECRUITING · NA
-
TaVNS for Delirium
RECRUITING · NA
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.